DI BATTISTA, MARCO Statistiche
DI BATTISTA, MARCO
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
Comparison of different forms of Raynaud's phenomenon by LASCA proximal-distal gradient perfusion.
2023-01-01 Di Battista, M; Morganti, R; Da Rio, M; De Mattia, G; Della Rossa, A; Mosca, M.
Is oropharyngoesophageal scintigraphy the method of choice for assessing dysphagia in systemic sclerosis? A single center experience.
2023-01-01 Di Battista, M; Grosso, M; Da Rio, M; De Mattia, G; Marciano, A; Valevich, A; Grosso, A; Morganti, R; Volterrani, D; Della Rossa, A; Mosca, M.
Kinetics of response to iloprost evaluated by laser speckle contrast analysis in systemic sclerosis
2023-01-01 Di Battista, M.; Da Rio, M.; Logiacco, A.; Barsotti, S.; Della Rossa, A.; Mosca, M.
Lung ultrasound and high-resolution computed tomography quantitative variations during nintedanib treatment for systemic sclerosis-associated interstitial lung disease.
2023-01-01 Di Battista, M; Delle Sedie, A; Romei, C; Tavanti, L; Da Rio, M; Morganti, R; Della Rossa, A; Mosca, M.
Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects
2023-01-01 Di Battista, Marco; Tavanti, Laura; Pistelli, Francesco; Carrozzi, Laura; Da Rio, Mattia; Rossi, Alessandra; Puccetti, Lorenzo; Tavoni, Antonio; Romei, Chiara; Morganti, Riccardo; Della Rossa, Alessandra; Mosca, Marta
Prostanoids in scleroderma microangiopathy: clinical and pharmacoeconomic comparison between two intravenous regimens
2021-01-01 Barsotti, S; Lorenzoni, V; Di Battista, M; D'Ascanio, A; Silvia, B; Puccetti, L; Turchetti, G; Della Rossa, A; Mosca, M
The impact of skin calcinosis on digital ulcers in patients with SSc: clinical and prognostic stratification using the “wound bed score”
2020-01-01 Barsotti, S.; Venturini, V.; Di Battista, M.; Janowska, A.; Dini, V.; Della Rossa, A.; Mosca, M.
Framingham, ACC/AHA or QRISK3: which is the best in systemic lupus erythematosus cardiovascular risk estimation?
2019-01-01 Di Battista, M; Tani, C; Elefante, E; Chimera, D; Carli, L; Ferro, F; Stagnaro, C; Mosca, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Comparison of different forms of Raynaud's phenomenon by LASCA proximal-distal gradient perfusion. | 1-gen-2023 | Di Battista, M; Morganti, R; Da Rio, M; De Mattia, G; Della Rossa, A; Mosca, M. | |
| Is oropharyngoesophageal scintigraphy the method of choice for assessing dysphagia in systemic sclerosis? A single center experience. | 1-gen-2023 | Di Battista, M; Grosso, M; Da Rio, M; De Mattia, G; Marciano, A; Valevich, A; Grosso, A; Morganti, R; Volterrani, D; Della Rossa, A; Mosca, M. | |
| Kinetics of response to iloprost evaluated by laser speckle contrast analysis in systemic sclerosis | 1-gen-2023 | Di Battista, M.; Da Rio, M.; Logiacco, A.; Barsotti, S.; Della Rossa, A.; Mosca, M. | |
| Lung ultrasound and high-resolution computed tomography quantitative variations during nintedanib treatment for systemic sclerosis-associated interstitial lung disease. | 1-gen-2023 | Di Battista, M; Delle Sedie, A; Romei, C; Tavanti, L; Da Rio, M; Morganti, R; Della Rossa, A; Mosca, M. | |
| Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects | 1-gen-2023 | Di Battista, Marco; Tavanti, Laura; Pistelli, Francesco; Carrozzi, Laura; Da Rio, Mattia; Rossi, Alessandra; Puccetti, Lorenzo; Tavoni, Antonio; Romei, Chiara; Morganti, Riccardo; Della Rossa, Alessandra; Mosca, Marta | |
| Prostanoids in scleroderma microangiopathy: clinical and pharmacoeconomic comparison between two intravenous regimens | 1-gen-2021 | Barsotti, S; Lorenzoni, V; Di Battista, M; D'Ascanio, A; Silvia, B; Puccetti, L; Turchetti, G; Della Rossa, A; Mosca, M | |
| The impact of skin calcinosis on digital ulcers in patients with SSc: clinical and prognostic stratification using the “wound bed score” | 1-gen-2020 | Barsotti, S.; Venturini, V.; Di Battista, M.; Janowska, A.; Dini, V.; Della Rossa, A.; Mosca, M. | |
| Framingham, ACC/AHA or QRISK3: which is the best in systemic lupus erythematosus cardiovascular risk estimation? | 1-gen-2019 | Di Battista, M; Tani, C; Elefante, E; Chimera, D; Carli, L; Ferro, F; Stagnaro, C; Mosca, M. |